Page 5 - P&g

CCI approves P&G's acquisition of 51.80% stake in drug firm Merck Ltd

The Competition Commission has approved Procter & Gamble's acquisition of 51.80 per cent stake in drug firm Merck Ltd, which is listed on the Indian bourses. The acquisition of 51.80 per cent stake in Merck Ltd by P&G for nearly Rs 1,290 crore is part of a global deal under which the latter is taking over German firm Merck KGaA's international consumer health business. The global deal is for about 3.4 billion euro in cash. In a tweet today, the Competition Commission of India (CCI) said it has approved acquisition of 51.80 per cent stake by P&G in consumer health business of Merck Ltd. The stake acquisition will be through Procter & Gamble Overseas India BV, an investment holding company held ultimately by P&G. According to the notice submitted to the CCI, P&G had proposed to acquire the consumer health business of Merck KGaA globally, pursuant to a sale and purchase agreement dated April 19, 2018 (Global SAPA). As part of the agreement, P&G had also ...

Procter & Gamble upbeat about Indian market as biz grows in double-digits

In India, P&G operates through two listed and one unlisted company, which together delivered a top line of Rs 90 billion for the financial year 2016-17

Procter & Gamble sees double-digit sales growth in Indian market in Q1

P&G's archrival Unilever had also said that it had delivered strong Q1 sales growth in emerging markets, led by an uptick in volume growth

As part of $4.2-bn global deal, P&G to acquire Merck India for Rs 12.9 bn

Deal part of its $4.2 billion global acquisition of German drug maker's consumer health business

P&G to acquire consumer health unit of Germany's Merck for about $4.21 bn

(Reuters) - Procter & Gamble Co said on Thursday it has signed an agreement to acquire the consumer health business of German pharmaceuticals company Merck KGaA for about 3.4 billion euros ($4.21 billion).

Procter and Gamble to continue reducing digital advertisement waste

P&G's digital spending in 2017 constituted a third of its global advertising budget of $7.1 billion

Procter & Gamble Q3 net dips 13% to Rs 1.31 bn on increased investment

The net profit of the FMCG company was Rs 1.5 billion in the corresponding quarter of the last fiscal

P&G Sept qtr net surges 11% to Rs 115 cr on higher income, lower expenses

FMCG firm Procter Gamble Hygiene and Health Care Ltd (P&G) today reported a 10.64 per cent increase in net profit at Rs 115.56 crore for the first quarter ended September 30. It had posted a net profit of Rs 104.44 crore in the July-September quarter a year ago, P&G said in a BSE filing. Its total income during the quarter under review was up 2.49 per cent to Rs 661.13 crore as against Rs 645.01 crore a year ago. P&G follows July to June as fiscal year. "Both the femine care and health care business delivered strong growth versus year ago behind brand fundamentals, strength of product portfolio and improved in-store execution," the company said in a statement. Its total expenses in Q1/FY 2017-18 were down marginally 0.22 per cent to Rs 483.39 crore as against Rs 484.48 crore. Share of Procter and Gamble Hygiene and Health Care Ltd today settled at Rs 8,729.50 apiece on the BSE, down 1.06 per cent from the previous close.

P&G Q2 profit and sales beat Wall Street estimates

Company has been shedding unprofitable brands as it focuses on core brands, to boost sales